Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

AHA Wrap-Up: Studies Emphasize Improved Outcomes, Cost Effectiveness

Executive Summary

Cardiovascular investigators are now asking new questions, including how can treatment be targeted to those most likely to benefit, and when does aggressive treatment become too much? At the 2006 American Heart Association (AHA) meeting, these questions were at the top of everyone's list, and several highly anticipated studies attempted to provide some answers.
Advertisement

Related Content

AHA Highlights: Improving Patient Care
Cost, Risk and Scientific Conservatism Dramatically Limit the Dealmaking for Heart Medicines.
InnerPulse: Bringing the Interventional Revolution to CRM
At TCT, DES Use and Safety Concerns: Irrational Exuberance or Irrational Anxiety?
Renewed DES Safety Debate Creates Second Generation Mover Advantage
Synecor's Golden Touch
A Wave of Success for Cambridge Heart
At TCT, A New Vision of the Device Industry
At AHA, A Debate Over Drug-Eluting Stents
Cardiovascular devices

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register

MT035037

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel